Good morning, just from Paul, as Graham doesn't work on Fridays (usually quiet for news). I've got a long list of backlog items, so I'll be putting in a full 6 hours today, to cover as many companies as I can by usual finish time of 13:00. Plus of course whatever news is delivered fresh on today's RNS.

That's it from us for this week. Have a lovely weekend, and as usual I'll be podcasting tomorrow.


Explanatory notes -

A quick reminder that we don’t recommend any stocks. We aim to review trading updates & results of the day and offer our opinions on them as possible candidates for further research if they interest you. Our opinions will sometimes turn out to be right, and sometimes wrong, because it's anybody's guess what direction market sentiment will take & nobody can predict the future with certainty. We are analysing the company fundamentals, not trying to predict market sentiment.

We stick to companies that have issued news on the day, with market caps up to about £700m. We avoid the smallest, and most speculative companies, and also avoid a few specialist sectors (e.g. natural resources, pharma/biotech).

A key assumption is that readers DYOR (do your own research), and make your own investment decisions. Reader comments are welcomed - please be civil, rational, and include the company name/ticker, otherwise people won't necessarily know what company you are referring to.


Agenda

Paul is writing all of today's report.

Long sections:

Revolution Beauty (LON:REVB) - a fascinating update today, following investigation of financial irregularities discovered in the accounts. Shares have been suspended since Sept 2022, but it sounds as if there's light at the end of a tunnel, with the company still solvent, and bank being supportive. Everyone should read today's announcement, as it details how the figures were fiddled. (more detail below)

MJ GLEESON (LON:GLE) [I hold] - a trading update that (as expected) reflects consumer caution, with a significantly reduced Dec 2022 (interim period end) closing order book.  Cancellation rate has improved in last 6 weeks, but new reservations down 25%.  Hence expect a soft H2 to June 2023 - which is now reflected in more realistic broker forecasts, and a bombed out share price. With an immaculate, ungeared balance sheet, and a remarkably low valuation (well below NTAV), I think this share…

Unlock the rest of this article with a 14 day trial

Already have an account?
Login here